ProMIS Neurosciences Inc. (TSX:PMN; OTCQB:ARFXF) is pleased to announce that it closed yesterday a private placement of 19,306,668 Units at the price of CDN$0.375 per Unit for gross proceeds of approximately CDN$ 7,240,000.

OSG chief executive Sam Norton tells Noble Capital conference that gains over last five months appear to be holding up. The first signs of a recovery may be showing for tanker rates in the recently slumping US Jones Act market.

Gray Television, Inc. (NYSE: GTN and GTN.A) announced today that it has completed its previously announced and priced underwritten public offering of shares of its common stock at a price to the public of $14.50 per share.

VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that the underwriters of its previously announced underwritten public offering have exercised their option to purchase an additional 2,100,000 shares.

NOBLE Life Science Partners (NOBLE LSP), a division of Noble Capital Markets Inc. welcomes Camillo Ricordi, M.D. to its Scientific Advisory Board (SAB)

Kratos Defense & Security Solutions, Inc. (“Kratos”) (Nasdaq:KTOS), announced today the pricing of an underwritten offering of 14,000,000 shares of its common stock at a public offering price of $12.25 per share.

Noble Capital Markets, Inc., acting as the exclusive placement agent for subscribers residing in the United States,

NOBLE Capital Markets, a leading small-cap focused investment firm, announces the initiation of research coverage of Vectrus Inc.

Noble Capital Markets announced today that it has initiated research coverage on Marlin Gold Ltd. (TSXV: MLN.V, OTCQX: MLNGF). The report was issued by Senior Research Analyst, Michael Heim, CFA.

Noble Capital Markets announced today that it has initiated research coverage on AAR Corp. (AIR). The report was issued by Research Analyst, Benjamin Klieve, CFA.

Noble Capital Markets announced today that it has initiated research coverage on DLH Holdings Corp. (DLHC). The report was issued by Senior Research Analyst, Mark Jordan, CFA.

Noble Capital Markets announced today that it has initiated research coverage on ESSA Pharma Inc. (EPIX). The report was issued by Noble's Head of Biotechnology Research, Kumar Raja, PhD.

Noble Capital Markets announced today that it has initiated research coverage on Endeavour Silver Corp. (EXK). The report was issued by Senior Research Analyst, Michael Heim, CFA.

Noble Capital Markets announced today that it has initiated research coverage on Anavex Life Sciences Corp. (AVXL) The report was issued by Noble's Head of Biotechnology Research, Kumar Raja, PhD.